16 stories mentioning SASE:4013Updated 6d ago
Every FINWIRES story that references SASE:4013, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Al Rajhi Capital on Wednesday decreased the price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 261 Saudi riyals from 277 riyals, while keeping its overweight rating.
Goldman Sachs on Tuesday increased the price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 284 Saudi riyals from 275 riyals, while affirming its neutral rating.
Aljazira Capital Co. on Sunday upgraded hospital operator Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to overweight from neutral and kept its price target at 270.70 Saudi riyals.
Arqaam Capital on Sunday upgraded Tadawul-listed medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to hold from sell and maintained its price target at 255 Saudi riyals.
The Tadawul All Share Index started the week 0.34% in the red as the escalating conflict in the Middle East dampened investor sentiment on Sunday.Yemen's Houthis launched attacks on Saudi Arabian oil installation structures on the Red Sea coast. The attacks struck Jizan- and Yanbu-based infrastructure that was owned by Saudi Arabian Oil Co. (SASE:2222), d/b/a Saudi Aramco, media reports said. Aramco shares closed 0.89% lower at closing.Saudi Arabia's merchandise exports in May increased 3.9% year over year, while non-oil exports dropped 26.1%. Imports, meanwhile, declined 19.5% during the period, according to a report by the General Authority for Statistics. The report also confirmed China as the kingdom's main merchandise trading partner."The ratio of non-oil exports (including re-exports) to imports decreased in May 2026, reaching 33.8% compared with 36.8% in May 2025. This decrease was driven by a 26.1% decrease in non-oil exports, alongside a 19.5% decrease in imports over the same period," the report said. "'Machinery, electrical equipment and parts' were among the most important non-oil export goods, accounting for 22.0% of the total non-oil exports, and decreasing by 31.6% compared with May 2025."On the corporate front, Modern Mills for Food Products Co. (SASE:2284) and Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) posted higher attributable net profit and revenue for the six months ended June 30. Modern Mills closed 0.49% in the red, while Dr. Sulaiman Al Habib Medical Services shares were 3.44% higher.Meanwhile, Anmat Technology for Trading (SASE:9639) shares closed flat as it secured a project worth 113.8 million Saudi riyals to deliver and install specialized equipment to the Ministry of Defense.
Morgan Stanley on Tuesday lowered the price target for hospital operator Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 264.50 Saudi riyals from 298 riyals and reiterated its overweight rating.
AlphaMena on Thursday raised the price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 185.00 Saudi riyals from 181.00 riyals and reiterated its sell rating.
Goldman Sachs on Friday lowered its price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 275 Saudi riyals from 315 riyals, while keeping its neutral rating.
EFG-Hermes Brokerage on Sunday lowered its price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 250 Saudi riyals from 260 riyals, while keeping its neutral rating.
Arqaam Capital on Tuesday reduced its price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 255 Saudi riyals from 270 riyals, while maintaining its sell rating.
AlphaMena on Thursday lowered the price target for Saudi Arabian medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 182.00 Saudi riyals from 210.00 riyals and reiterated its sell rating.
HSBC on Wednesday decreased the price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 306 Saudi riyals from 320 riyals, while affirming its buy rating.
Ubhar Capital Oman on Monday downgraded Saudi medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to hold from buy and lowered its price target to 247.10 Saudi riyals from 278.00 riyals.
Arqaam Capital on Sunday downgraded Saudi medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to sell from buy and decreased its price target to 270.00 Saudi riyals from 280.00 riyals.
Arqaam Capital on Wednesday reduced its price target for medical company Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 280 Saudi riyals from 300 riyals, keeping its buy rating.
SNB Capital on Wednesday raised Saudi Arabian medical company Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to overweight from neutral, while decreasing its price target to 291.70 Saudi riyals from 293.60 riyals.
